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358a Monday, February 27, 2012in myofilament Ca2þ sensitivity was abolished by the expression of b-Tm. Fur-
thermore, the McTnT 45-74 deletion-induced reduction in cooperativity of
force production was more pronounced under a b-Tm background. Thus, our
data shows that changes in the isoform expression of Tm modify T1-
dependent cardiac function, indicating that T1-Tm interactions exert a modula-
tory role in regulating cardiac thin filament activation.
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In the heart, stimulation of b-adrenergic pathway and subsequent activation
of protein kinase A (PKA) is known to increase myocardial contractility. The
increase in contractility is, in part, due to target phosphorylation of troponin
I (TnI). In this study, we sought to identify novel target sites for PKA that
could potentially contribute to this increase in contractility. To induce phos-
phorylation of TnI, cardiac and fast skeletal muscle from 3-4 month old
Sprague Dawley rats was mechanically disrupted and demembranated fol-
lowed by incubation with the catalytic subunit of PKA (50U PKA/ 3mg tis-
sue , 0-30 min). To identify target specific phosphorylation on fast skeletal
(fsTnI) or cardiac (cTnI) TnI, western blot analysis with phospho-specific
antibodies was performed. PKA treatment increased phosphorylation of
cTnI at ser22/23, as expected, but also at ser149. Similarly, PKA treatment
increased phosphorylation of fsTnI at ser117, which is the equivalent to
ser149 in cTnI. Accordingly, fsTnI demonstrated no observable phosphory-
lation at ser22/23. Adenosine-monophosphate activated kinase (AMPK) has
been shown to target ser149 of cTnI. Therefore, to validate PKA-
dependent phosphorylation of cTnI at ser149, hearts were excised and per-
fused with AICAR, a known activator of AMPK. AICAR-perfused hearts
demonstrated a time-dependent increase in phosphorylation of cTnI at
ser149. These results demonstrate that PKA-dependent phosphorylation can
target ser149 in cTnI and, equivalently, ser117 in fsTnI. The functional con-
sequence of this target site phosphorylation and how it impacts contractility
is currently under investigation.
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Dilated Cardiomyopathy (DCM) and Familial Hypertrophic Cardiomyopathy
(FHC) are pathological heart conditions mainly associated with sarcomeric
mutations that lead to contractile dysfunction. Despite the identification of
several mutations associated with FHC and DCM, the role of these mutations
in pathological cardiac-remodeling is still elusive. Therefore, we studied
length-dependent contractile parameters of murine hearts expressing DCM-
associated mutation (D230N in alpha-tropomyosin) and FHC-associated
mutation (R92L in cTnT). Mechanical studies were carried out on
detergent-skinned cardiac muscle fibers at sarcomere length (SL) 1.9 and
2.3 mm. Our preliminary results show that myofilament Ca2þ sensitivity and
cooperativity are affected differently in both mutants, irrespective of SL.
Ca2þ sensitivity was decreased in the D230N fibers, but increased in R92L fi-
bers. Ca2þ-activated maximal tension was unaltered in both examples. Coop-
erativity of myofilament activation was significantly decreased in R92L fibers
and significantly increased in D230N fibers. Our results suggest that single
amino acid substitution mutations in Tm (D230N) and TnT (R92L) cause di-
verse functional effects, which may correlate with varied pathological remod-
eling. Further mechano-dynamic studies are planned to determine if other
aspects of myofilament activation may be involved in the evolution of compli-
cations associated with DCM and FHC.
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The FHC-related cTnC mutation, L29Q, is located at the dysfunctional bind-
ing site I of cTnC and interacts with the N-terminus of cardiac troponin I
(cTnI) during muscle contraction. Recent studies suggest that the L29Q
cTnC mutation affects Ca2þ activation and the transduction of PKA-dependent phosphorylation (S23/24) cTnI effect on cTnC, but the results
are contradictory. Therefore, to investigate whether the L29Q cTnC mutation
abrogates the effects of PKA-dependent phosphorylation of cTnI of the
Ca2þ sensitivity of cTnC, we examined the Ca2þ binding properties in mul-
tiple biochemical systems of increasing complexity. Mouse cTn was recon-
stituted with phosphomimetic cTnI (S23/24D), cTnT, and IAANS-labeled
control TnC (T53C, C84S, C35S) 5 the L29Q mutation. Steady-state
Ca2þ binding and Ca2þ dissociation rates were measured in the isolated
cTn as well as the reconstituted thin filaments. There was no significant dif-
ference between steady-state Ca binding for the control cTn (0.9850.07mM)
and L29Q cTn (0.9950.08mM), nor a difference in the Ca2þ dissociation
kinetics of reconstituted thin filaments, control (300510/s) and L29Q
(280510/s). However, L29Q cTnC in skinned cardiac myocytes increased
Ca sensitivity by 1.2 fold and reduced the decrease in Ca2þ sensitivity
caused by phosphomimetic cTnI by ~ 45%, as well as the enhanced length
dependent Ca2þ sensitivity. These results suggest that the Ca2þ association
rate, rather than the dissociation rate was affected by L29Q in the reconsti-
tuted thin filament. In conclusion, the cTnC L29Q mutation increased Ca2þ
sensitivity of force generation and exacerbated the functional effects of TnI
phosphorylation at S23/24 in skinned cardiac myocytes, but did not alter
changes in the Ca2þ dissociation rate in the reconstituted thin filament
caused by phosphomimetic cTnI.
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Doxorubicin (adriamycin) is an effective anti-cancer drug, but its clinical us-
age is limited by a dose-dependent cardiotoxicity characterized by widespread
sarcomere disarray and loss of myofilaments. Cardiac ankyrin repeat protein
(CARP, ANKRD1) is a transcriptional regulatory protein that is extremely
susceptible to doxorubicin, however, the mechanism(s) of doxorubicin-
induced CARP suppression and its specific role in cardiomyocyte biology re-
mains to be elucidated. In this study, we report that treatment of cardiomyo-
cytes with doxorubicin resulted in complete suppression of CARP promoter
activity, decreased CARP protein levels, and marked sarcomere disarray.
Transfection of CARP siRNA in cardiomyocytes resulted in a complete de-
pletion of CARP and significant disruption of sarcomere ultrastructure.
Adenoviral overexpression of CARP, however, was unable to rescue the
doxorubicin-induced sarcomere disarray phenotype. GATA4 has previously
been shown to regulate CARP, thus we examined the role of GATA4 in
doxorubicin-induced CARP depletion. Cardiomyocytes treated with doxorubi-
cin show a concomitant depletion of CARP and GATA4 protein levels.
GATA4 siRNA inhibits while GATA4 overexpression enhances CARP pro-
moter activity in cardiomyocytes. Both GATA4 and CARP siRNA signifi-
cantly repressed titin and actin promoter activity. These data show that in
cardiomyocytes transcription factor GATA4 is upstream of CARP and that
doxorubicin induces a rapid down-regulation of GATA4 resulting in inhibi-
tion of CARP transcription. Our data further support a role for a GATA4/
CARP signaling axis in sarcomere maintenance and that suppression of this
pathway contributes, in part, to the overall pathophysiology of doxorubicin
cardiomyopathy.
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We are interested in the mechanism of phosphorylation of smooth muscle my-
osin (SMM) by the myosin light chain kinase -calmodulin-Ca2þ complex
(MLCK-CaM-Ca2þ). This reaction is required for activation of SMM catalytic
activity and smooth muscle contraction. In previous studies we characterized
tightly-bound SMM-MLCK-CaM complexes in an in vitro model system and
demonstrated that SMM-MLCK-CaM complexes co-purified from smooth
muscle were functional, i.e. MLCK was able to phosphorylate SMM and the
phosphorylated SMM resulted in actin filament motility in an in vitro assay.
Moreover, using total internal reflectance fluorescence microscopy (TIRF),
we observed dynamic interactions between single MLCK and SMM molecules
by visualizing quantum dot-labeled MLCK (QD-MLCK) interacting with
SMM aligned on actin filaments.We have also observed that QDs-MLCK
moved along the pure actin filaments. We are currently using cultured human
